NeuroTherapia has completed enrollment of its Phase 1 single dose study of NTRX-07 in normal volunteers. Top line data is expected to be...

NeuroTherapia, Inc., a Cleveland Clinic spin-off company, has started its first-in-human Phase I clinical trial of NTRX-07, a new drug...

CLEVELAND, OH – NeuroTherapia, Inc., a Cleveland Clinic spin-off company, will be starting clinical trials of NTRX-07, a new drug...

NeuroTherapia has received funding from the Alzheimer's Association to support the first human trials of NTRX-07, a novel new therapy...

NeuroTherapia, Inc. has received a $1.7 million commitment from the Alzheimer’s Drug Discovery Foundation (ADDF) to advance its drug...

A new Cleveland Clinic spinoff company has raised an initial $1 million to advance the development of a new therapeutic to take on...

Sotheby's in New York City is famous for dealing in works of art and antiques,but at the Alzheimer’s Drug Discovery Foundation’s (ADDF)...